Documentation of pharmacist interventions in the emergency department

American Journal of Health-System Pharmacy

Volumn 62, Issue 17, 2005, Pages 1793-1797

  Ling, Jennifer M ^a,f   Mike, Leigh Ann ^b   Rubin, Julie ^b   Abraham, Prasad ^c   Howe, Andrew ^d   Patka, John ^e   Vigliotti, Debbie ^f  

^a Georgia Poison Center   (United States)

^b Internal Medicine

^c Emergency Medicine

^d Pharmacoeconomics Outcomes Research   (United States)

^e Emergency Care Center

^f GRADY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CLINICAL PHARMACY; DRUG CROSS REACTIVITY; EMERGENCY WARD; HEALTH CARE ACCESS; HUMAN; PERSONAL DIGITAL ASSISTANT; PHARMACIST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 24144481193     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040588     Document Type: Article

References (29)

1. Elenbaas RM, Waeckerle JF, McNabney WK. The clinical pharmacist in emergency medicine. Am J Hosp Pharm. 1977; 34:843-6.
2. Powell MF, Solomon DK, McEachen RA. Twenty-four hour emergency pharmaceutical services. Am J Hosp Pharm. 1985; 42:831-5.
3. Levy DB. Documentation of clinical and cost-saving pharmacy interventions in the emergency room. Hosp Pharm. 1993; 28:624-7,630-4,653.
4. Fairbanks RJ, Hays DP, Webster DF et al. Clinical pharmacy services in an emergency department. Am J Health-Syst Pharm. 2004; 61:934-7.
5. Mialon PJ, Williams P, Wiebe RA. Clinical pharmacy services in a pediatric emergency room. Hosp Pharm. 2004; 39:121-4.
6. Silva MA, Tataronis GR, Maas B. Using personal digital assistants to document pharmacist cognitive services and estimate potential reimbursement. Am J Health-Syst Pharm. 2003; 60:911-5.
7. Reilly JC, Wallace M, Campbell MM. Tracking pharmacist interventions with a hand-held computer. Am J Health-Syst Pharm. 2001; 58:158-61.
8. Simonian AI. Documenting pharmacist interventions on an intranet. Am J Health-Syst Pharm. 2003; 60:151-5.
9. Lynx DH, Brockmiller HR, Connelly RT et al. Use of a PDA-based pharmacist intervention system. Am J Health-Syst Pharm. 2003; 60:2341-4.
10. Ong SW, Tailor SA, Walker SE. Application of a Palm OS patient monitoring tool in an infectious diseases consult service. Can J Hosp Pharm. 2003; 56:218-25.
11. Lau A, Balen RM, Lam R et al. Using a personal digital assistant to document clinical pharmacy services in an intensive care unit. Am J Health-Syst Pharm. 2001; 58:1229-32.
12. Bosinski TJ, Campbell L, Schwartz S. Using a personal digital assistant to document pharmacotherapeutic interventions. Am J Health-Syst Pharm. 2004; 61:931-4.
13. Johnson JA, Bootman JL. Drug-related morbidity and mortality. Arch Intern Med. 1995; 155:1949-56.
14. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11.
15. Boyko WL Jr, Yurkowski PJ, Ivey MF et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health-Syst Pharm. 1997; 54:1591-5.
16. Suseno M, Tedeski L, Kent S et al. Impact of documented pharmacists' interventions on patient care and cost. Hosp Pharm. 1998; 33:676-81.
17. Mutnick AH, Sterba KJ, Peroutka JA et al. Cost savings and avoidance from clinical interventions. Am J Health-Syst Pharm. 1997; 54:392-6.
18. McMullin ST, Hennenfent JA, Ritchie DJ et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999; 159:2306-9.
19. Nesbit TW, Shermock KM, Bobek MB et al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am J Health-Syst Pharm. 2001; 58:784-90.
20. Strand LM, Morley PC, Cipolle RJ et al. Drug-related problems: their structure and function. DICP. 1990; 24:1093-7.
21. Kinky DE, Brush SC, Laskin MS et al. Economic impact of a drug information service. Ann Pharmacother. 1999; 33:11-6.
22. Kinky DE, Edden ME, Howe AM et al. The potential cost savings of pharmacists' interventions measured by drug costs adverse events avoided. Am J Health-Syst Pharm. 1998; 55:2178. Abstract.
23. Schneider PJ, Gift MG, Lee YP et al. Cost of medication-related problems at a university hospital. Am J Health-Syst Pharm. 1995; 52:2415-8.
24. Halfhill RT. Tom's inflation calculator. www.halfhill.com/inflation.html (accessed 2003 Oct 15).
25. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
26. Lee AJ, Boro MS, Knapp KK et al. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health-Syst Pharm. 2002; 59:2070-7.
27. Sayles TJ. Documentation of pharmacists' interventions and associated cost savings. Am J Health-Syst Pharm. 2004; 61:838,840. Letter.
28. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003; 29:691-8.
29. Kucukarslan SN, Peters M, Mlynarek M et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003; 163:2014-8.